Chimerix (STU:CXF) 3-Year EBITDA Growth Rate : -13.90% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Chimerix 3-Year EBITDA Growth Rate?

Chimerix's EBITDA per Share for the three months ended in Mar. 2024 was €-0.25.

During the past 3 years, the average EBITDA Per Share Growth Rate was -13.90% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Chimerix was 22.30% per year. The lowest was -115.70% per year. And the median was 9.90% per year.

Competitive Comparison of Chimerix's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Chimerix's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chimerix's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chimerix's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Chimerix's 3-Year EBITDA Growth Rate falls into.

Chimerix 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Chimerix (STU:CXF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Chimerix 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Chimerix's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chimerix (STU:CXF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chimerix Inc (STU:CXF) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

CMRX:USA CXF:Germany

Address

2505 Meridian Parkway, Suite 100, Durham, NC, USA, 27713

Website

https://www.chimerix.com

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through license agreements and a federal contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) for research and advanced development of drugs to treat various human diseases. The company operates only in one business segment namely pharmaceuticals.

Chimerix (STU:CXF) Headlines

No Headlines